Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05791786 · ClinicalTrials.gov registry record
The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)
A clinical trial of Amniotic Fluid Embolism, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT05791786 is a study of Amniotic Fluid Embolism that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05791786, a study of Amniotic Fluid Embolism, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,
Conditions Studied
Interventions
- OTHER Patient
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2031-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05791786
The ClinicalTrials.gov registry entry for NCT05791786 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amniotic Fluid Embolism appearing as the primary indexed condition, and to 1 intervention - of which Patient is the first listed.
NCT05791786 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05791786 about?
NCT05791786 is a clinical study titled "The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)". To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,
What is the current status of trial NCT05791786?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2022-07-05. Estimated completion is 2031-12-31.
What conditions does trial NCT05791786 study?
This clinical trial studies the following conditions: Amniotic Fluid Embolism.
What interventions are being tested in trial NCT05791786?
The interventions under investigation include: Patient (OTHER).
Who is sponsoring clinical trial NCT05791786?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05791786 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.